IPSC

Century Therapeutics, Inc. IPSC

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IPSC GLUE NKTX LYEL GBIO SANA ERAS EWTX JANX
6M 12.12 % 140.59 % 40.59 % 89.65 % 73.26 % 145.86 % 94.35 % 19.22 % -11.12 %
YTD -46.18 % 49.23 % -4.40 % 30.70 % -41.62 % 169.70 % -10.74 % -45.62 % -51.67 %
1Y -62.18 % 115.65 % -39.34 % -29.16 % -73.55 % 10.97 % -12.36 % -53.80 % -47.86 %
3Y -94.19 % 36.55 % -82.02 % -87.11 % -88.45 % -12.23 % -66.29 % 41.07 % 97.32 %
5Y -97.55 % -49.91 % -91.97 % -95.01 % -97.43 % -87.32 % -86.17 % -51.00 % 2.31 %
10Y -97.55 % -49.91 % -95.01 % -95.01 % -97.38 % -87.32 % -86.17 % -51.00 % 2.31 %
From the beginning -97.55 % -49.91 % -95.01 % -95.01 % -97.38 % -87.32 % -86.17 % -51.00 % 2.31 %

Dividend